Use of human GH in elderly patients with accidental hip fracture

European Journal of Endocrinology

Volumn 143, Issue 5, 2000, Pages 585-592

  Van der Lely, A J ^a   Lamberts, S W ^a   Jauch, K W ^a   Swierstra, B A ^a   Hertlein, H ^a   De Vries, D D ^a   Birkett, M A ^a   Bates, P C ^a   Blum, W F ^a   Attanasio, A F ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; ELDERLY CARE; FEMALE; FUNCTIONAL ASSESSMENT; HIP FRACTURE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION;

EID: 0033669036     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430585     Document Type: Article

References (36)

1. WHO Study Group Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
2. Treatment of hip fracture in Finland and Sweden. Prospective comparison of 788 cases in three hospitals
3. The apparent incidence of hip fracture in Europe: A study of national register sources. MEDOS Study Group
4. Epidemiology of fractures of the proximal femur
5. Increase in the incidence of hip fractures and of the ratio of trochanteric to cervical hip fractures in Belgium
6. Hip fractures in the elderly: A world-wide projection
7. Functional recovery after hip fracture
8. Prospective comparison of hip fracture treatment. 856 Cases followed for 4 months in The Netherlands and Sweden
9. Mortality and morbidity after hip fractures
10. Ambulation outcomes after hip fracture
11. Protein depletion and metabolic stress in elderly patients who have a fracture of the hip
12. Low IGF-I levels in hip fracture patients. A comparison of 20 coxarthrotic and 23 hip fracture patients
13. The link between nutritional status and clinical outcome: Can nutritional intervention modify it?
14. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial
15. Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Role of hormonal-substrate environment
16. Growth hormone administration conserves lean body mass during dietary restriction in obese subjects
17. Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent
18. The effects of human growth hormone administration in elderly adults with recent weight loss
19. Growth hormone treatment for burned children
20. Exogenous growth hormone: Effects on the catabolic response to surgically produced acute stress and on postoperative immune function
21. Enhancement of protein synthesis efficiency in parenterally fed trauma victims by adjuvant recombinant human growth hormone
22. Improving the sensitivity of the Barthel Index for stroke rehabilitation
23. Accelerated rehabilitation after proximal femoral fracture: A randomized controlled trial
24. Ambulatory ability after hip fracture. A prospective study in geriatric patients
25. Hip fractures in geriatric patients. Results of an interdisciplinary hospital care program
26. Changing patterns of hip fracture care before and after implementation of the prospective payment system
27. Prognostic indicators and early home rehabilitation in elderly patients with hip fractures
28. Hip fracture
29. Protein intake, IGF-I and osteoporosis
30. Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men
31. Acquired growth hormone resistance in catabolic states
32. Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition
33. Dose-dependent effects of human growth hormone on postoperative substrate metabolism
34. Increased mortality associated with growth hormone treatment in critically ill adults